Atika Capital Management’s Verona Pharma VRNA Stock Holding History

Atika Capital Management’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-176,000	Closed	-$18.8M	–	114
2025 Q3	$18.8M	Sell	176,000 -36,500	-17%	-$3.81M	1.51%	22
2025 Q2	$20.1M	Buy	212,500 +4,366	+2%	+$323K	2.01%	18
2025 Q1	$13.2M	Sell	208,134 -3,866	-2%	-$231K	1.86%	18
2024 Q4	$9.85M	Buy	212,000 +140,000	+194%	+$5.26M	1.05%	30
2024 Q3	$2.07M	Buy	+72,000	New	+$1.77M	0.21%	77

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Atika Capital Management's VRNA Position: Q4 2025 in Review

Atika Capital Management sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 176,000 shares — an estimated $18.8M sold.

Atika Capital Management first reported a position in VRNA in Q3 2024 and held it in 5 quarters. The position peaked at $20.1M in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Atika Capital Management reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Atika Capital Management sold 176,000 Verona Pharma shares in Q4 2025, an estimated $18.8M.
Atika Capital Management first reported a position in Verona Pharma in Q3 2024 and held it in 5 quarters.
Atika Capital Management's Verona Pharma position peaked at $20.1M in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Atika Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.